Circio Holding ASA Market Cap ($294.21 Million)
Market Cap & Net Worth: Circio Holding ASA (CRNA)
Circio Holding ASA market cap. Circio Holding ASA (OL:CRNA) has a market capitalization of $294.21 Million (Nkr2.80 Billion) as of November 1, 2026. Listed on the OL stock exchange, this Norway-based company holds position #14620 globally and #117 in its home market, demonstrating a -4.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Circio Holding ASA's stock price Nkr10.20 by its total outstanding shares 274109510 (274.11 Million). Also see cash flow conversion of Circio Holding ASA for how efficiently the company converts equity into cash flow.
Circio Holding ASA Market Cap History (2015–2026)
Circio Holding ASA market cap history from 2015 to 2026. Data shows change from $9.96 Billion to $294.21 Million (-28.39% CAGR). Check Circio Holding ASA (CRNA) stock price for real-time trading data and today's change.
Circio Holding ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Circio Holding ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Circio Holding ASA (CRNA) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1688.44x
Circio Holding ASA's market cap is 1688.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $6.00 Billion | $624.00K | -$108.13 Million | 9617.26x | N/A |
| 2022 | $948.40 Million | $10.00 Million | -$432.90 Million | 94.82x | N/A |
| 2023 | $207.68 Million | $123.00K | -$112.94 Million | 1688.44x | N/A |
Competitor Companies of CRNA by Market Capitalization
Companies near Circio Holding ASA in the global market cap rankings as of November 1, 2026. Also see how large is Circio Holding ASA's balance sheet for a full breakdown of the balance sheet.
Key companies related to Circio Holding ASA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Circio Holding ASA (2015–2026)
Market capitalization of Circio Holding ASA from 2015 to today. Between 2015 and today, Circio Holding ASA's market cap moved from $9.96 Billion to $ 294.21 Million, with a yearly change of -28.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr294.21 Million | +776.29% |
| 2025 | Nkr33.57 Million | +63.94% |
| 2024 | Nkr20.48 Million | -90.14% |
| 2023 | Nkr207.68 Million | -78.10% |
| 2022 | Nkr948.40 Million | -50.41% |
| 2021 | Nkr1.91 Billion | -68.13% |
| 2020 | Nkr6.00 Billion | +10.50% |
| 2019 | Nkr5.43 Billion | +28.61% |
| 2018 | Nkr4.22 Billion | -57.89% |
| 2017 | Nkr10.03 Billion | +43.46% |
| 2016 | Nkr6.99 Billion | -29.81% |
| 2015 | Nkr9.96 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Circio Holding ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $294.21 Million USD |
| MoneyControl | $294.21 Million USD |
| MarketWatch | $294.21 Million USD |
| marketcap.company | $294.21 Million USD |
| Reuters | $294.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Circio Holding ASA
Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in hu… Read more